MAGE Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of MAGE Antibodies for advanced research in cancer immunology. MAGE Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MAGE (Melanoma Antigen Gene) proteins are a family of tumor-associated antigens that play a significant role in the immune response against cancer cells. MAGE proteins are primarily expressed in malignant tissues and serve as targets for cancer immunotherapy due to their restricted expression in normal tissues. Understanding MAGE protein expression patterns helps researchers identify potential therapeutic targets in various cancer types. MAGE protein research continues to reveal new insights into tumor development and progression mechanisms. Investigating MAGE protein interactions with other cellular components advances our knowledge of cancer cell survival and proliferation. Current research focuses on how MAGE proteins influence tumor immune evasion and treatment resistance. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing cancer biology understanding and developing innovative therapeutic approaches.